BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Shamar Young, Donna D’Souza, Siobhan Flanagan, Jafar Golzarian. Review of the Clinical Evidence for the Use of DEBIRI in the Treatment of Colorectal Metastatic DiseaseCardioVascular and Interventional Radiology 2017; 40(4): 496 doi: 10.1007/s00270-016-1537-5
2
Ron C. Gaba, R. Peter Lokken, Ryan M. Hickey, Andrew J. Lipnik, Robert J. Lewandowski, Riad Salem, Daniel B. Brown, T. Gregory Walker, James E. Silberzweig, Mark Otto Baerlocher, Ana Maria Echenique, Mehran Midia, Jason W. Mitchell, Siddharth A. Padia, Suvranu Ganguli, Thomas J. Ward, Jeffrey L. Weinstein, Boris Nikolic, Sean R. Dariushnia. Quality Improvement Guidelines for Transarterial Chemoembolization and Embolization of Hepatic MalignancyJournal of Vascular and Interventional Radiology 2017; 28(9): 1210 doi: 10.1016/j.jvir.2017.04.025
3
Young Hong, Robert C. G. Martin. Personalizing Locoregional Therapy for Patients with Metastatic Colorectal CancerCurrent Colorectal Cancer Reports 2017; 13(2): 126 doi: 10.1007/s11888-017-0356-7
4
Jeffrey Chakedis, Malcolm H. Squires, Eliza W. Beal, Tasha Hughes, Heather Lewis, Anghela Paredes, Mazen Al-Mansour, Steven Sun, Jordan M. Cloyd, Timothy M. Pawlik. Update on current problems in colorectal liver metastasisCurrent Problems in Surgery 2017; 54(11): 554 doi: 10.1067/j.cpsurg.2017.10.002
5
Vincenzo Di Noia, Michele Basso, Valentina Marsico, Eleonora Cerchiaro, Sabrina Rossi, Ettore D'Argento, Antonia Strippoli, Giovanni Schinzari, Roberto Iezzi, Alessandra Cassano, Carlo Barone. DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancerFuture Oncology 2019; 15(20): 2349 doi: 10.2217/fon-2017-0025
6
Olaguoke Akinwande, Meaghan Dendy, Johannes M. Ludwig, Hyun S. Kim. Hepatic intra-arterial injection of irinotecan drug eluting beads (DEBIRI) for patients with unresectable colorectal liver metastases: A systematic reviewSurgical Oncology 2017; 26(3): 268 doi: 10.1016/j.suronc.2017.05.003
7
Arash Fereydooni, Brian Letzen, Mansur A. Ghani, Milena A. Miszczuk, Steffen Huber, Julius Chapiro, Todd Schlachter, Jean-Francois Geschwind, Christos Georgiades. Irinotecan-Eluting 75–150-μm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I StudyJournal of Vascular and Interventional Radiology 2018; 29(12): 1646 doi: 10.1016/j.jvir.2018.08.010
8
Diamantis I. Tsilimigras, Ioannis Ntanasis-Stathopoulos, Fabio Bagante, Demetrios Moris, Jordan Cloyd, Eleftherios Spartalis, Timothy M. Pawlik. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidenceSurgical Oncology 2018; 27(2): 280 doi: 10.1016/j.suronc.2018.05.012
9
Giammaria Fiorentini, Donatella Sarti, Camillo Aliberti, Riccardo Carandina, Andrea Mambrini, Stefano Guadagni. Multidisciplinary approach of colorectal cancer liver metastasesWorld Journal of Clinical Oncology 2017; 8(3): 190-202 doi: 10.5306/wjco.v8.i3.190
10
Mark McGregor, Gonzalo Tapia Rico, Amanda Townsend, Tim Price. Cancer Management and Therapy2018;  doi: 10.5772/intechopen.73014